Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
17.2M
-
Number of holders
-
37
-
Total 13F shares, excl. options
-
3.78M
-
Shares change
-
+1.62M
-
Total reported value, excl. options
-
$14.8M
-
Value change
-
+$6.06M
-
Number of buys
-
17
-
Number of sells
-
-16
-
Price
-
$3.91
Significant Holders of Journey Medical Corp - Common Stock (DERM) as of Q4 2024
43 filings reported holding DERM - Journey Medical Corp - Common Stock as of Q4 2024.
Journey Medical Corp - Common Stock (DERM) has 37 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3.78M shares
of 17.2M outstanding shares and own 21.97% of the company stock.
Largest 10 shareholders include TANG CAPITAL MANAGEMENT LLC (1.73M shares), Cambridge Investment Research Advisors, Inc. (328K shares), VANGUARD GROUP INC (325K shares), RENAISSANCE TECHNOLOGIES LLC (236K shares), AMERICAN FINANCIAL GROUP INC (180K shares), PVG ASSET MANAGEMENT CORP (168K shares), GEODE CAPITAL MANAGEMENT, LLC (109K shares), ENVESTNET ASSET MANAGEMENT INC (104K shares), Geneos Wealth Management Inc. (63.3K shares), and Integrated Wealth Concepts LLC (58.9K shares).
This table shows the top 37 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.